Pancreatic cancer (PC) is a major cause of cancer-associated mortality in Western countries (and estimated to be the second cause of cancer deaths by 2030). The main form of PC is pancreatic adenocarcinoma, which is the fourth most common cause of cancer-related death, and this situation has remained virtually unchanged for several decades. Pancreatic ductal adenocarcinoma (PDAC) is inherently linked to the unique physiology and microenvironment of the exocrine pancreas, such as pH, mechanical stress, and hypoxia. Of them, calcium (Ca2+) signals, being pivotal molecular devices in sensing and integrating signals from the microenvironment, are emerging to be particularly relevant in cancer. Mutations or aberrant expression of key proteins that control Ca2+ levels can cause deregulation of Ca2+-dependent effectors that control signaling pathways determining the cells’ behavior in a way that promotes pathophysiological cancer hallmarks, such as enhanced proliferation, survival and invasion. So far, it is essentially unknown how the cancer-associated Ca2+ signaling is regulated within the characteristic landscape of PDAC. This work provides a complete overview of the Ca2+ signaling and its main players in PDAC. Special consideration is given to the Ca2+ signaling as a potential target in PDAC treatment and its role in drug resistance.
Metastatic cancer cells and immune cells spread throughout the body via the bloodstream, reaching target sites for immune clearance or establishing secondary tumors in distant organs. As they move from blood circulation to a targeted organ, cells adhere to activated endothelium and then extravasate through it into a tissue-rich environment. The molecular mechanisms that drive the extravasation of immune and cancer cells are not yet fully understood. Most importantly, the phenotypic state identity of the disseminated cancer cells has yet to be characterized. While various sealed microfluidic devices have been developed to study extravasation, few, if any, allow for the efficient collection of extravasated cells. To address this limitation, we designed a biomimetic microfluidic device comprising a network of 3D blood capillaries and a customizable collecting chamber, separated by a porous membrane. Our device enables (i) real-time monitoring of cell extravasation through the endothelium via live imaging and (ii) the collection of disseminated cells for subsequent molecular characterization. We validated the functional properties of the 3D endothelial layer under shear stress and inflammation induction. After injecting promyeloblast cells and metastatic cancer cells into the lumen of the capillary network, we observed cell rolling and extravasation under continuous flow conditions. Finally, we collected extravasated cancer cells for gene expression profiling by real time–quantitative polymerase chain reaction. Overall, our novel microfluidic device reconstitutes a functional 3D blood vessel network, allowing real-time observation of extravasation and the collection of disseminated cells for further characterization.
Le cancer du sein est le cancer le plus diagnostiqué chez la femme à l'échelle mondiale. Si le dépistage précoce et l'innovation thérapeutique ont nettement amélioré les taux de survie, le pronostic s'assombrit considérablement lors de l'atteinte d'organes vitaux. De fait, 90 % de la mortalité liée à cette pathologie est imputable au développement métastatique. Parmi les différents sous-types, le cancer du sein triple négatif (TNBC) se distingue par son agressivité et son fort potentiel migratoire. Près de 46 % des patientes atteintes de TNBC développeront des métastases, avec un tropisme cérébral marqué dans 47 % des cas. Cette localisation compromet gravement la survie — réduite à six mois en moyenne — en raison des limites de l'exérèse chirurgicale et de la rareté des cibles thérapeutiques spécifiques.Dans ce contexte, caractériser la dissémination cérébrale précoce est crucial pour identifier les mécanismes responsables de cette colonisation. Les objectifs de ma thèse consistent à : (1) développer un modèle d'étude robuste, (2) élucider la cinétique de ce développement ainsi que l'interaction des cellules tumorales disséminées (DTC) avec le microenvironnement neuronal, et (3) identifier les acteurs moléculaires de cette phase précoce.Pour y parvenir, nous avons mis au point un modèle préclinique in vivo par injections intracardiaques de cellules cancéreuses chez des souris SCID. Ce dispositif a permis d'analyser de façon spatio-temporelle la dissémination métastatique cérébrale par bioluminescence et imagerie 3D in toto. Parallèlement, un protocole de collecte des DTC à différents stades et sites (cerveau, poumons et tumeurs sous-cutanées) a été établi afin de caractériser leurs profils transcriptomiques et d'isoler des biomarqueurs spécifiques du tropisme cérébral.L'ensemble de ces travaux contribue à une meilleure compréhension de la physiopathologie métastatique du TNBC, en alliant une cartographie précise de la dissémination cellulaire à une analyse moléculaire approfondie des cellules capables de franchir la barrière hémato-encéphalique.
Phenotypic plasticity is a major factor of tumor heterogeneity and treatment resistance. In particular, cancer stem cells (CSCs) represent a small subpopulation within tumors with self-renewal and tumor-forming capabilities. Understanding reprogramming, maintenance, and lineage properties of CSCs requires dedicated tools to disentangle the respective influences of phenotypic inheritance and cell-cell interactions. Here we set up ultra-wide field microscopy of breast cancer cell lines expressing a stemness fluorescent reporter for several days. The fluorescent reporter distinguishes three phenotypes: cancer stem cells (CSCs), cancer differentiated cells (CDCs) and intermediate/transiting cancer cells (iCCs). Spatial statistics indicate significant zonation, aka phenotypic niches, with CSC clustering near each other but away from CDCs. Surprisingly, single cell time series reveal spontaneous reprogramming events from CDC to CSC even in unperturbed populations. We identify that such transitions are prone to arise during the cell cycle. Moreover, lineage analysis shows that the phenotype is partially inherited from ancestor cells. However, such heredity is not sufficient to explain the spatial properties of the cell population, which also depend on cell-cell interactions. Indeed, we identified that phenotypic transitions of cancer cells are influenced by the phenotypic state of neighboring cells. Reprogramming into CSCs is respectively promoted and inhibited by the presence of CSCs and CDCs in the neighborhood. Altogether, our results disentangle how phenotypic inheritance and intercellular interactions orchestrate the spatio-temporal self-organization of cancer cell heterogeneity, maintaining a subpopulation of CSCs within niches.
About Me
Master Student in Biology and Health at the University of Lille. Specialized in oncology.
Master Student in Biology and Health at the University of Lille. Specialized in oncology.